-
www.talkingquality.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
www.qualitymeasures.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
www.cahps.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
www.cpsi.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
cahps.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
healthcare411.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
monahrq.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
patientregistry.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
talkingquality.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
ahrqpubs.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
teamstepps.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - For Project 1, the aims were to:
Detect the presence and duration of vascular and urinary catheter
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
March 01, 2020 - estimated that 300,000 to 600,000 Americans are affected each year by VTE, making it the third
leading vascular
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-mosops-database-report-part-I.pdf
January 01, 2022 - Pulmonary Medicine 21 2%
Radiology 2 <1%
Rheumatology 9 1%
Surgery (All) 56 6%
Urology 19 2%
Vascular
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-mosops-database-report-part-I.pdf
January 01, 2022 - Pulmonary Medicine 21 2%
Radiology 2 <1%
Rheumatology 9 1%
Surgery (All) 56 6%
Urology 19 2%
Vascular
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-fullreport.pdf
December 17, 2019 - course of CT and MRI studies, intravenous (IV) contrast media may be used to
enhance visualization of vascular